Literature DB >> 23427745

Solitary lung metastasis after radical prostatectomy in presence of undetectable PSA.

Pietro Pepe1, Filippo Fraggetta, Francesco Tornabene, Maurizio Nicolosi, Francesco Aragona.   

Abstract

Clinical recurrence in the absence of biochemical PSA failure is uncommon and accounts for less than 1%; we report a rare case of solitary lung metastasis in a patient with undetectable PSA level (<0.1 ng/mL) after radical prostatectomy (RP) for prostate cancer (PCa). An asymptomatic 75-year-old man nine years after RP showed a solitary lung mass (about 2 cm) at chest radiography; the 18-FDG-PET/CT confirmed the presence of an isolated mass suspicious for primitive pulmonary cancer. The initial histological specimen after RP showed a mixed acinar and ductal PCa (Gleason score 7, pT3aNO stage, negative surgical margins). A segmental pulmonary resection was performed and definitive specimen demonstrated a single ductal PCa metastasis; after six months from surgery the patient was free from recurrence. In conclusion, in patients with atypical PCa variants imaging studies may be considered in the follow up even in presence of undetectable PSA because they could benefit from early salvage therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23427745

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  2 in total

1.  [Sub-threshold prostate-specific antigen levels after resection of metachronous pulmonary metastases].

Authors:  A Spek; C Faber; C Stief
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

Review 2.  Solitary pulmonary metastasis from prostate cancer with neuroendocrine differentiation: a case report and review of relevant cases from the literature.

Authors:  Toshiya Maebayashi; Katsumi Abe; Takuya Aizawa; Masakuni Sakaguchi; Naoya Ishibash; Shoko Fukushima; Taku Honma; Yoshiaki Kusumi; Tsuyoshi Matsui; Nozomu Kawata
Journal:  World J Surg Oncol       Date:  2015-05-07       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.